|
Real-time Estimate
Cboe BZX
12:56:56 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 97.28 USD | +0.08% |
|
+4.88% | +22.98% |
| 09-03 | Cvs Health Announces Updated 2026-2027 Covid-19 Vaccines Available At Cvs Pharmacy and Minuteclinic Locations | CI |
| 09-03 | CVS Health Reports Availability of Updated COVID-19 Vaccines | MT |
| Market Cap | 124B 107B 101B 91.94B 172B 11,737B 172B 1,189B 462B 6,022B 467B 457B 19,400B | P/E 2026 * |
14.3x | P/E 2027 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise Value | 176B 152B 143B 130B 244B 16,638B 244B 1,686B 654B 8,537B 662B 647B 27,501B | EV / Sales 2026 * |
0.42x | EV / Sales 2027 * | 0.4x |
| Free-Float |
71.17% | Yield 2026 * |
2.74% | Yield 2027 * | 2.82% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
CBOE
| CVS | Real-time | |
|
Mexican S.E.
| CVS * | End-of-day quote | |
|
Tradegate
| CVS | Real-time | |
|
Xetra
| CVS | Delayed | |
|
Boerse Muenchen
| CVS | Real-time | |
|
London S.E.
| 0HRS | Delayed | |
|
CBOE
| Real-time | ||
|
Deutsche Boerse AG
| CVS | Delayed | |
|
Santiago S.E.
| CVSCL | End-of-day quote | |
|
Swiss Exchange
| CVS | Delayed | |
|
CBOE
| 0HRS | Real-time | |
|
Santiago S.E.
| CVS | End-of-day quote | |
|
Borsa Italiana
| 1CVS | End-of-day quote | |
|
Lima
| CVSUS | End-of-day quote | |
|
Wiener Boerse
| CVS | End-of-day quote | |
|
Börse Stuttgart
| CVS | Delayed | |
|
Swiss Exchange
| CVS | Delayed |
Last Transcript : CVS Health Corporation
| 1 day | +0.19% | ||
| 1 week | +4.88% | ||
| Current month | +3.93% | ||
| 1 month | -6.53% | ||
| 3 months | +2.93% | ||
| 6 months | +21.14% | ||
| Current year | +22.98% |
| 1 week | 92.85 |  | 98.5 |
| 1 month | 92.35 | | 101 |
| Current year | 69.51 | | 110.68 |
| 1 year | 69.51 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 5/21/26 | Glenview Capital Management LLC
| Sell | Company | -748,462 | 0.0584% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.08% | +4.88% | +32.45% | +48.76% | 124B | |
| -0.67% | -3.00% | -1.53% | +47.78% | 88.59B | |
| -1.38% | -4.27% | -4.93% | +50.22% | 28.95B | |
| -0.49% | -1.94% | +32.17% | +87.09% | 26.42B | |
| -0.26% | -4.48% | -4.92% | -5.03% | 21.46B | |
| +0.46% | -0.88% | +37.36% | +245.04% | 21.22B | |
| +0.56% | +6.15% | -3.64% | +29.28% | 15.97B | |
| +1.61% | -1.75% | -5.97% | -12.02% | 11.89B | |
| +0.70% | +1.27% | +34.98% | +89.32% | 11.58B | |
| -0.93% | -2.28% | -15.29% | +71.23% | 10.24B | |
| Average | -0.03% | -0.92% | +10.07% | +65.17% | 36.06B | |
| Weighted average by Cap. | -0.15% | +0.28% | +15.01% | +58.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418B 359B 338B 309B 578B 39,440B 580B 3,996B 1,551B 20,236B 1,569B 1,534B 65,190B | 429B 369B 347B 317B 593B 40,482B 595B 4,102B 1,592B 20,770B 1,610B 1,575B 66,912B |
| Net income | 8.78B 7.55B 7.1B 6.49B 12.14B 829B 12.17B 83.95B 32.58B 425B 32.95B 32.23B 1,369B | 9.11B 7.84B 7.38B 6.74B 12.6B 860B 12.64B 87.15B 33.82B 441B 34.21B 33.46B 1,422B |
| Net Debt | 51.91B 44.67B 42.02B 38.39B 71.82B 4,901B 72.01B 497B 193B 2,514B 195B 191B 8,100B | 48.85B 42.04B 39.55B 36.13B 67.59B 4,613B 67.78B 467B 181B 2,367B 183B 179B 7,624B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$97.60 | +0.41% | 1,695,839 |
| 26-09-03 | US$97.20 | -0.03% | 4,783,706 |
| 26-09-02 | US$97.23 | -0.38% | 5,403,775 |
| 26-09-01 | US$97.60 | +3.93% | 8,614,487 |
| 26-08-31 | US$93.91 | +0.91% | 10,676,760 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
